MAPK3 and neoplasm: The expression of DR4 and p-ERK1/2 in the isolated tumor tissues was in agreement with the above findings in vitro: bestatin substantially increased the DR4 levels and decreased phosphorylation of ERK1/2 (*P < 0.05) (Figure 8B and 8C).